Fosun Pharma Gains on Plan to Buy China Hospital Operator

Shanghai Fosun Pharmaceutical Group Co. headed for a record high in Shanghai trading after saying it had teamed up with TPG Capital to buy Chindex International Inc., in a deal valuing the hospital operator at $369 million.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.